Its specificity and sensitivity to identify the BRAF V600E gene mutation have been verified in many series of tumors, including melanoma and PTC, and it could be used as a surrogate of genetic detection of BRAF V600E mutation [5–7]. The gene discussed is BRAF; the disease is melanoma.